nodes	percent_of_prediction	percent_of_DWPC	metapath
Vincristine—muscle cancer—urinary bladder cancer	0.269	0.544	CtDrD
Vincristine—kidney cancer—urinary bladder cancer	0.225	0.456	CtDrD
Vincristine—RALBP1—Doxorubicin—urinary bladder cancer	0.0448	0.129	CbGbCtD
Vincristine—ABCC10—Gemcitabine—urinary bladder cancer	0.0338	0.0975	CbGbCtD
Vincristine—ABCC10—Etoposide—urinary bladder cancer	0.0241	0.0696	CbGbCtD
Vincristine—ABCC3—Fluorouracil—urinary bladder cancer	0.0182	0.0524	CbGbCtD
Vincristine—ABCC10—Doxorubicin—urinary bladder cancer	0.0164	0.0475	CbGbCtD
Vincristine—ABCC10—Methotrexate—urinary bladder cancer	0.0159	0.046	CbGbCtD
Vincristine—ABCC3—Cisplatin—urinary bladder cancer	0.0154	0.0445	CbGbCtD
Vincristine—ABCC3—Etoposide—urinary bladder cancer	0.0152	0.0438	CbGbCtD
Vincristine—ABCC1—Epirubicin—urinary bladder cancer	0.012	0.0345	CbGbCtD
Vincristine—ABCB1—Mitomycin—urinary bladder cancer	0.0109	0.0316	CbGbCtD
Vincristine—ABCC3—Doxorubicin—urinary bladder cancer	0.0103	0.0299	CbGbCtD
Vincristine—ABCC3—Methotrexate—urinary bladder cancer	0.01	0.0289	CbGbCtD
Vincristine—ABCC1—Etoposide—urinary bladder cancer	0.00931	0.0269	CbGbCtD
Vincristine—ABCB11—Doxorubicin—urinary bladder cancer	0.00894	0.0258	CbGbCtD
Vincristine—ABCC2—Carboplatin—urinary bladder cancer	0.00821	0.0237	CbGbCtD
Vincristine—ABCG2—Fluorouracil—urinary bladder cancer	0.00747	0.0215	CbGbCtD
Vincristine—ABCG2—Carboplatin—urinary bladder cancer	0.00742	0.0214	CbGbCtD
Vincristine—ABCC2—Cisplatin—urinary bladder cancer	0.00701	0.0202	CbGbCtD
Vincristine—ABCC2—Etoposide—urinary bladder cancer	0.00689	0.0199	CbGbCtD
Vincristine—ABCC1—Doxorubicin—urinary bladder cancer	0.00635	0.0183	CbGbCtD
Vincristine—ABCG2—Cisplatin—urinary bladder cancer	0.00634	0.0183	CbGbCtD
Vincristine—ABCG2—Etoposide—urinary bladder cancer	0.00623	0.018	CbGbCtD
Vincristine—ABCC1—Methotrexate—urinary bladder cancer	0.00615	0.0178	CbGbCtD
Vincristine—CYP3A4—Thiotepa—urinary bladder cancer	0.00496	0.0143	CbGbCtD
Vincristine—ABCC2—Doxorubicin—urinary bladder cancer	0.0047	0.0136	CbGbCtD
Vincristine—ABCC2—Methotrexate—urinary bladder cancer	0.00455	0.0131	CbGbCtD
Vincristine—ABCG2—Doxorubicin—urinary bladder cancer	0.00425	0.0123	CbGbCtD
Vincristine—ABCG2—Methotrexate—urinary bladder cancer	0.00412	0.0119	CbGbCtD
Vincristine—CYP3A5—Etoposide—urinary bladder cancer	0.00345	0.00996	CbGbCtD
Vincristine—ABCB1—Gemcitabine—urinary bladder cancer	0.00315	0.00908	CbGbCtD
Vincristine—ABCB1—Cisplatin—urinary bladder cancer	0.00229	0.0066	CbGbCtD
Vincristine—ABCB1—Etoposide—urinary bladder cancer	0.00225	0.00648	CbGbCtD
Vincristine—ABCB1—Doxorubicin—urinary bladder cancer	0.00153	0.00442	CbGbCtD
Vincristine—ABCB1—Methotrexate—urinary bladder cancer	0.00148	0.00428	CbGbCtD
Vincristine—CYP3A4—Etoposide—urinary bladder cancer	0.00135	0.00388	CbGbCtD
Vincristine—CYP3A4—Doxorubicin—urinary bladder cancer	0.000918	0.00265	CbGbCtD
Vincristine—TUBA4A—prostate gland—urinary bladder cancer	0.000878	0.022	CbGeAlD
Vincristine—NR0B1—female reproductive system—urinary bladder cancer	0.00086	0.0215	CbGeAlD
Vincristine—RALBP1—prostate gland—urinary bladder cancer	0.000828	0.0207	CbGeAlD
Vincristine—TUBA4A—seminal vesicle—urinary bladder cancer	0.000743	0.0186	CbGeAlD
Vincristine—TUBB6—Zalcitabine—Gemcitabine—urinary bladder cancer	0.000728	0.582	CbGdCrCtD
Vincristine—TUBB4A—prostate gland—urinary bladder cancer	0.000704	0.0176	CbGeAlD
Vincristine—RALBP1—seminal vesicle—urinary bladder cancer	0.0007	0.0175	CbGeAlD
Vincristine—TUBB2B—prostate gland—urinary bladder cancer	0.00068	0.017	CbGeAlD
Vincristine—TUBA4A—epithelium—urinary bladder cancer	0.000645	0.0162	CbGeAlD
Vincristine—TUBB—prostate gland—urinary bladder cancer	0.000644	0.0161	CbGeAlD
Vincristine—TUBB2A—prostate gland—urinary bladder cancer	0.00064	0.016	CbGeAlD
Vincristine—TUBB6—prostate gland—urinary bladder cancer	0.000632	0.0158	CbGeAlD
Vincristine—CYP3A4—urine—urinary bladder cancer	0.000628	0.0157	CbGeAlD
Vincristine—TUBA4A—smooth muscle tissue—urinary bladder cancer	0.000622	0.0156	CbGeAlD
Vincristine—TUBA4A—renal system—urinary bladder cancer	0.000599	0.015	CbGeAlD
Vincristine—TUBA4A—urethra—urinary bladder cancer	0.000588	0.0147	CbGeAlD
Vincristine—RALBP1—smooth muscle tissue—urinary bladder cancer	0.000586	0.0147	CbGeAlD
Vincristine—TUBB2B—seminal vesicle—urinary bladder cancer	0.000575	0.0144	CbGeAlD
Vincristine—RALBP1—renal system—urinary bladder cancer	0.000564	0.0141	CbGeAlD
Vincristine—ABCC3—prostate gland—urinary bladder cancer	0.000556	0.0139	CbGeAlD
Vincristine—RALBP1—urethra—urinary bladder cancer	0.000554	0.0139	CbGeAlD
Vincristine—ABCC10—prostate gland—urinary bladder cancer	0.000553	0.0139	CbGeAlD
Vincristine—TUBB4B—prostate gland—urinary bladder cancer	0.000549	0.0138	CbGeAlD
Vincristine—TUBB—seminal vesicle—urinary bladder cancer	0.000545	0.0136	CbGeAlD
Vincristine—TUBB2A—seminal vesicle—urinary bladder cancer	0.000542	0.0136	CbGeAlD
Vincristine—TUBB6—seminal vesicle—urinary bladder cancer	0.000534	0.0134	CbGeAlD
Vincristine—TUBB4A—renal system—urinary bladder cancer	0.00048	0.012	CbGeAlD
Vincristine—TUBA4A—female reproductive system—urinary bladder cancer	0.000479	0.012	CbGeAlD
Vincristine—SLC22A3—prostate gland—urinary bladder cancer	0.000473	0.0118	CbGeAlD
Vincristine—ABCC10—seminal vesicle—urinary bladder cancer	0.000468	0.0117	CbGeAlD
Vincristine—TUBB4B—seminal vesicle—urinary bladder cancer	0.000464	0.0116	CbGeAlD
Vincristine—TUBB6—epithelium—urinary bladder cancer	0.000464	0.0116	CbGeAlD
Vincristine—TUBB2B—renal system—urinary bladder cancer	0.000464	0.0116	CbGeAlD
Vincristine—TUBB—smooth muscle tissue—urinary bladder cancer	0.000456	0.0114	CbGeAlD
Vincristine—TUBB2B—urethra—urinary bladder cancer	0.000456	0.0114	CbGeAlD
Vincristine—TUBB2A—smooth muscle tissue—urinary bladder cancer	0.000453	0.0114	CbGeAlD
Vincristine—RALBP1—female reproductive system—urinary bladder cancer	0.000452	0.0113	CbGeAlD
Vincristine—TUBB6—smooth muscle tissue—urinary bladder cancer	0.000447	0.0112	CbGeAlD
Vincristine—ABCC2—prostate gland—urinary bladder cancer	0.000444	0.0111	CbGeAlD
Vincristine—TUBA4A—vagina—urinary bladder cancer	0.000434	0.0109	CbGeAlD
Vincristine—TUBB—urethra—urinary bladder cancer	0.000431	0.0108	CbGeAlD
Vincristine—TUBB6—renal system—urinary bladder cancer	0.000431	0.0108	CbGeAlD
Vincristine—TUBB2A—urethra—urinary bladder cancer	0.000429	0.0107	CbGeAlD
Vincristine—TUBB6—urethra—urinary bladder cancer	0.000423	0.0106	CbGeAlD
Vincristine—RALBP1—vagina—urinary bladder cancer	0.000409	0.0102	CbGeAlD
Vincristine—SLC22A3—seminal vesicle—urinary bladder cancer	0.0004	0.01	CbGeAlD
Vincristine—ABCC1—prostate gland—urinary bladder cancer	0.000391	0.0098	CbGeAlD
Vincristine—TUBB4B—smooth muscle tissue—urinary bladder cancer	0.000389	0.00974	CbGeAlD
Vincristine—TUBB4A—female reproductive system—urinary bladder cancer	0.000384	0.00962	CbGeAlD
Vincristine—ABCC3—renal system—urinary bladder cancer	0.000379	0.00949	CbGeAlD
Vincristine—ABCC10—renal system—urinary bladder cancer	0.000377	0.00944	CbGeAlD
Vincristine—TUBB4B—renal system—urinary bladder cancer	0.000374	0.00937	CbGeAlD
Vincristine—TUBB2B—female reproductive system—urinary bladder cancer	0.000371	0.0093	CbGeAlD
Vincristine—TUBB—Azacitidine—Gemcitabine—urinary bladder cancer	0.000371	0.296	CbGdCrCtD
Vincristine—ABCC10—urethra—urinary bladder cancer	0.00037	0.00927	CbGeAlD
Vincristine—TUBB4B—urethra—urinary bladder cancer	0.000368	0.00921	CbGeAlD
Vincristine—TUBB2A—female reproductive system—urinary bladder cancer	0.00035	0.00875	CbGeAlD
Vincristine—TUBB6—female reproductive system—urinary bladder cancer	0.000345	0.00864	CbGeAlD
Vincristine—TUBB2B—vagina—urinary bladder cancer	0.000336	0.00841	CbGeAlD
Vincristine—SLC22A3—smooth muscle tissue—urinary bladder cancer	0.000335	0.00839	CbGeAlD
Vincristine—ABCC1—seminal vesicle—urinary bladder cancer	0.000331	0.00829	CbGeAlD
Vincristine—ABCG2—prostate gland—urinary bladder cancer	0.000324	0.00811	CbGeAlD
Vincristine—SLC22A3—renal system—urinary bladder cancer	0.000322	0.00808	CbGeAlD
Vincristine—TUBB—vagina—urinary bladder cancer	0.000318	0.00796	CbGeAlD
Vincristine—SLC22A3—urethra—urinary bladder cancer	0.000317	0.00793	CbGeAlD
Vincristine—TUBB2A—vagina—urinary bladder cancer	0.000316	0.00792	CbGeAlD
Vincristine—TUBB6—vagina—urinary bladder cancer	0.000312	0.00781	CbGeAlD
Vincristine—ABCC3—female reproductive system—urinary bladder cancer	0.000303	0.0076	CbGeAlD
Vincristine—ABCC2—renal system—urinary bladder cancer	0.000303	0.00758	CbGeAlD
Vincristine—ABCC10—female reproductive system—urinary bladder cancer	0.000302	0.00756	CbGeAlD
Vincristine—CYP3A5—prostate gland—urinary bladder cancer	0.000301	0.00753	CbGeAlD
Vincristine—TUBB4B—female reproductive system—urinary bladder cancer	0.0003	0.00751	CbGeAlD
Vincristine—TUBA4A—lymph node—urinary bladder cancer	0.00028	0.00702	CbGeAlD
Vincristine—ABCG2—seminal vesicle—urinary bladder cancer	0.000274	0.00686	CbGeAlD
Vincristine—ABCC10—vagina—urinary bladder cancer	0.000273	0.00684	CbGeAlD
Vincristine—TUBB4B—vagina—urinary bladder cancer	0.000271	0.00679	CbGeAlD
Vincristine—RALBP1—lymph node—urinary bladder cancer	0.000264	0.00662	CbGeAlD
Vincristine—ABCC1—urethra—urinary bladder cancer	0.000262	0.00656	CbGeAlD
Vincristine—SLC22A3—female reproductive system—urinary bladder cancer	0.000258	0.00647	CbGeAlD
Vincristine—ABCC2—female reproductive system—urinary bladder cancer	0.000242	0.00607	CbGeAlD
Vincristine—SLC22A3—vagina—urinary bladder cancer	0.000234	0.00585	CbGeAlD
Vincristine—TUBB4A—lymph node—urinary bladder cancer	0.000225	0.00563	CbGeAlD
Vincristine—TUBB2B—lymph node—urinary bladder cancer	0.000217	0.00544	CbGeAlD
Vincristine—ABCG2—urethra—urinary bladder cancer	0.000217	0.00543	CbGeAlD
Vincristine—TUBB—lymph node—urinary bladder cancer	0.000206	0.00515	CbGeAlD
Vincristine—CYP3A5—renal system—urinary bladder cancer	0.000205	0.00513	CbGeAlD
Vincristine—TUBB2A—lymph node—urinary bladder cancer	0.000205	0.00512	CbGeAlD
Vincristine—TUBB6—lymph node—urinary bladder cancer	0.000202	0.00505	CbGeAlD
Vincristine—ABCC1—vagina—urinary bladder cancer	0.000193	0.00484	CbGeAlD
Vincristine—ABCC3—lymph node—urinary bladder cancer	0.000177	0.00444	CbGeAlD
Vincristine—ABCC10—lymph node—urinary bladder cancer	0.000177	0.00442	CbGeAlD
Vincristine—TUBB4B—lymph node—urinary bladder cancer	0.000175	0.00439	CbGeAlD
Vincristine—ABCG2—vagina—urinary bladder cancer	0.00016	0.004	CbGeAlD
Vincristine—ABCB1—prostate gland—urinary bladder cancer	0.00016	0.004	CbGeAlD
Vincristine—CYP3A4—renal system—urinary bladder cancer	0.000154	0.00385	CbGeAlD
Vincristine—TUBB6—Azacitidine—Gemcitabine—urinary bladder cancer	0.000153	0.122	CbGdCrCtD
Vincristine—SLC22A3—lymph node—urinary bladder cancer	0.000151	0.00378	CbGeAlD
Vincristine—CYP3A5—vagina—urinary bladder cancer	0.000148	0.00372	CbGeAlD
Vincristine—ABCC2—lymph node—urinary bladder cancer	0.000142	0.00355	CbGeAlD
Vincristine—ABCB1—seminal vesicle—urinary bladder cancer	0.000135	0.00338	CbGeAlD
Vincristine—ABCC1—lymph node—urinary bladder cancer	0.000125	0.00313	CbGeAlD
Vincristine—CYP3A4—female reproductive system—urinary bladder cancer	0.000123	0.00308	CbGeAlD
Vincristine—ABCB1—epithelium—urinary bladder cancer	0.000117	0.00294	CbGeAlD
Vincristine—ABCB1—renal system—urinary bladder cancer	0.000109	0.00273	CbGeAlD
Vincristine—ABCB1—urethra—urinary bladder cancer	0.000107	0.00268	CbGeAlD
Vincristine—ABCG2—lymph node—urinary bladder cancer	0.000103	0.00259	CbGeAlD
Vincristine—ABCB1—female reproductive system—urinary bladder cancer	8.72e-05	0.00218	CbGeAlD
Vincristine—ABCB1—vagina—urinary bladder cancer	7.88e-05	0.00197	CbGeAlD
Vincristine—Nervous system disorder—Cisplatin—urinary bladder cancer	7.06e-05	0.000912	CcSEcCtD
Vincristine—Thrombocytopenia—Cisplatin—urinary bladder cancer	7.05e-05	0.00091	CcSEcCtD
Vincristine—Musculoskeletal discomfort—Gemcitabine—urinary bladder cancer	7.04e-05	0.000909	CcSEcCtD
Vincristine—Convulsion—Etoposide—urinary bladder cancer	7e-05	0.000904	CcSEcCtD
Vincristine—Dehydration—Epirubicin—urinary bladder cancer	7e-05	0.000903	CcSEcCtD
Vincristine—Hyponatraemia—Doxorubicin—urinary bladder cancer	6.99e-05	0.000902	CcSEcCtD
Vincristine—Insomnia—Gemcitabine—urinary bladder cancer	6.99e-05	0.000902	CcSEcCtD
Vincristine—Hypertension—Etoposide—urinary bladder cancer	6.98e-05	0.000901	CcSEcCtD
Vincristine—Pain in extremity—Doxorubicin—urinary bladder cancer	6.96e-05	0.000899	CcSEcCtD
Vincristine—Hyperhidrosis—Cisplatin—urinary bladder cancer	6.96e-05	0.000899	CcSEcCtD
Vincristine—Paraesthesia—Gemcitabine—urinary bladder cancer	6.94e-05	0.000895	CcSEcCtD
Vincristine—Musculoskeletal discomfort—Fluorouracil—urinary bladder cancer	6.92e-05	0.000893	CcSEcCtD
Vincristine—Insomnia—Fluorouracil—urinary bladder cancer	6.87e-05	0.000887	CcSEcCtD
Vincristine—Anorexia—Cisplatin—urinary bladder cancer	6.86e-05	0.000886	CcSEcCtD
Vincristine—Paraesthesia—Fluorouracil—urinary bladder cancer	6.82e-05	0.00088	CcSEcCtD
Vincristine—Aspartate aminotransferase increased—Epirubicin—urinary bladder cancer	6.77e-05	0.000875	CcSEcCtD
Vincristine—Hypersensitivity—Thiotepa—urinary bladder cancer	6.76e-05	0.000873	CcSEcCtD
Vincristine—Hypotension—Cisplatin—urinary bladder cancer	6.73e-05	0.000869	CcSEcCtD
Vincristine—Decreased appetite—Gemcitabine—urinary bladder cancer	6.71e-05	0.000867	CcSEcCtD
Vincristine—Gastrointestinal disorder—Gemcitabine—urinary bladder cancer	6.67e-05	0.000861	CcSEcCtD
Vincristine—Fatigue—Gemcitabine—urinary bladder cancer	6.66e-05	0.00086	CcSEcCtD
Vincristine—Muscular weakness—Epirubicin—urinary bladder cancer	6.63e-05	0.000857	CcSEcCtD
Vincristine—Cardiac arrest—Doxorubicin—urinary bladder cancer	6.62e-05	0.000854	CcSEcCtD
Vincristine—Pain—Gemcitabine—urinary bladder cancer	6.6e-05	0.000853	CcSEcCtD
Vincristine—Constipation—Gemcitabine—urinary bladder cancer	6.6e-05	0.000853	CcSEcCtD
Vincristine—Decreased appetite—Fluorouracil—urinary bladder cancer	6.6e-05	0.000852	CcSEcCtD
Vincristine—Pancytopenia—Methotrexate—urinary bladder cancer	6.6e-05	0.000852	CcSEcCtD
Vincristine—Anaphylactic shock—Etoposide—urinary bladder cancer	6.6e-05	0.000852	CcSEcCtD
Vincristine—Asthenia—Thiotepa—urinary bladder cancer	6.59e-05	0.000851	CcSEcCtD
Vincristine—Musculoskeletal discomfort—Cisplatin—urinary bladder cancer	6.56e-05	0.000847	CcSEcCtD
Vincristine—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	6.56e-05	0.000847	CcSEcCtD
Vincristine—Infection—Etoposide—urinary bladder cancer	6.55e-05	0.000846	CcSEcCtD
Vincristine—Ataxia—Doxorubicin—urinary bladder cancer	6.54e-05	0.000845	CcSEcCtD
Vincristine—Dysuria—Methotrexate—urinary bladder cancer	6.5e-05	0.000839	CcSEcCtD
Vincristine—Neutropenia—Methotrexate—urinary bladder cancer	6.5e-05	0.000839	CcSEcCtD
Vincristine—Pain—Fluorouracil—urinary bladder cancer	6.49e-05	0.000838	CcSEcCtD
Vincristine—Dehydration—Doxorubicin—urinary bladder cancer	6.47e-05	0.000836	CcSEcCtD
Vincristine—Paraesthesia—Cisplatin—urinary bladder cancer	6.46e-05	0.000835	CcSEcCtD
Vincristine—Thrombocytopenia—Etoposide—urinary bladder cancer	6.46e-05	0.000834	CcSEcCtD
Vincristine—Erectile dysfunction—Methotrexate—urinary bladder cancer	6.4e-05	0.000826	CcSEcCtD
Vincristine—Hyperhidrosis—Etoposide—urinary bladder cancer	6.38e-05	0.000823	CcSEcCtD
Vincristine—Photosensitivity reaction—Methotrexate—urinary bladder cancer	6.34e-05	0.000819	CcSEcCtD
Vincristine—Anorexia—Etoposide—urinary bladder cancer	6.29e-05	0.000812	CcSEcCtD
Vincristine—Diarrhoea—Thiotepa—urinary bladder cancer	6.28e-05	0.000811	CcSEcCtD
Vincristine—Aspartate aminotransferase increased—Doxorubicin—urinary bladder cancer	6.27e-05	0.000809	CcSEcCtD
Vincristine—Decreased appetite—Cisplatin—urinary bladder cancer	6.26e-05	0.000808	CcSEcCtD
Vincristine—Pneumonia—Methotrexate—urinary bladder cancer	6.23e-05	0.000804	CcSEcCtD
Vincristine—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	6.22e-05	0.000802	CcSEcCtD
Vincristine—Depression—Methotrexate—urinary bladder cancer	6.18e-05	0.000797	CcSEcCtD
Vincristine—Pancytopenia—Epirubicin—urinary bladder cancer	6.17e-05	0.000797	CcSEcCtD
Vincristine—Hypotension—Etoposide—urinary bladder cancer	6.16e-05	0.000796	CcSEcCtD
Vincristine—Pain—Cisplatin—urinary bladder cancer	6.16e-05	0.000795	CcSEcCtD
Vincristine—Muscular weakness—Doxorubicin—urinary bladder cancer	6.14e-05	0.000793	CcSEcCtD
Vincristine—Body temperature increased—Gemcitabine—urinary bladder cancer	6.11e-05	0.000788	CcSEcCtD
Vincristine—Neutropenia—Epirubicin—urinary bladder cancer	6.08e-05	0.000785	CcSEcCtD
Vincristine—Dysuria—Epirubicin—urinary bladder cancer	6.08e-05	0.000785	CcSEcCtD
Vincristine—Dizziness—Thiotepa—urinary bladder cancer	6.07e-05	0.000784	CcSEcCtD
Vincristine—Stomatitis—Methotrexate—urinary bladder cancer	6.04e-05	0.00078	CcSEcCtD
Vincristine—Body temperature increased—Fluorouracil—urinary bladder cancer	6e-05	0.000775	CcSEcCtD
Vincristine—Sweating—Methotrexate—urinary bladder cancer	5.94e-05	0.000767	CcSEcCtD
Vincristine—Photosensitivity reaction—Epirubicin—urinary bladder cancer	5.93e-05	0.000766	CcSEcCtD
Vincristine—Paraesthesia—Etoposide—urinary bladder cancer	5.92e-05	0.000765	CcSEcCtD
Vincristine—Weight decreased—Epirubicin—urinary bladder cancer	5.88e-05	0.000759	CcSEcCtD
Vincristine—Vomiting—Thiotepa—urinary bladder cancer	5.84e-05	0.000754	CcSEcCtD
Vincristine—Pneumonia—Epirubicin—urinary bladder cancer	5.83e-05	0.000753	CcSEcCtD
Vincristine—Rash—Thiotepa—urinary bladder cancer	5.79e-05	0.000747	CcSEcCtD
Vincristine—Dermatitis—Thiotepa—urinary bladder cancer	5.78e-05	0.000747	CcSEcCtD
Vincristine—Headache—Thiotepa—urinary bladder cancer	5.75e-05	0.000743	CcSEcCtD
Vincristine—Decreased appetite—Etoposide—urinary bladder cancer	5.73e-05	0.00074	CcSEcCtD
Vincristine—Pancytopenia—Doxorubicin—urinary bladder cancer	5.71e-05	0.000738	CcSEcCtD
Vincristine—Gastrointestinal disorder—Etoposide—urinary bladder cancer	5.69e-05	0.000735	CcSEcCtD
Vincristine—Body temperature increased—Cisplatin—urinary bladder cancer	5.69e-05	0.000735	CcSEcCtD
Vincristine—Fatigue—Etoposide—urinary bladder cancer	5.69e-05	0.000734	CcSEcCtD
Vincristine—Neuropathy peripheral—Epirubicin—urinary bladder cancer	5.68e-05	0.000734	CcSEcCtD
Vincristine—Stomatitis—Epirubicin—urinary bladder cancer	5.65e-05	0.00073	CcSEcCtD
Vincristine—Pain—Etoposide—urinary bladder cancer	5.64e-05	0.000728	CcSEcCtD
Vincristine—Constipation—Etoposide—urinary bladder cancer	5.64e-05	0.000728	CcSEcCtD
Vincristine—Neutropenia—Doxorubicin—urinary bladder cancer	5.62e-05	0.000726	CcSEcCtD
Vincristine—Dysuria—Doxorubicin—urinary bladder cancer	5.62e-05	0.000726	CcSEcCtD
Vincristine—Hypersensitivity—Fluorouracil—urinary bladder cancer	5.59e-05	0.000722	CcSEcCtD
Vincristine—Sweating—Epirubicin—urinary bladder cancer	5.56e-05	0.000718	CcSEcCtD
Vincristine—Asthenia—Gemcitabine—urinary bladder cancer	5.54e-05	0.000716	CcSEcCtD
Vincristine—Urinary tract disorder—Methotrexate—urinary bladder cancer	5.49e-05	0.000709	CcSEcCtD
Vincristine—Photosensitivity reaction—Doxorubicin—urinary bladder cancer	5.49e-05	0.000709	CcSEcCtD
Vincristine—Nausea—Thiotepa—urinary bladder cancer	5.45e-05	0.000704	CcSEcCtD
Vincristine—Urethral disorder—Methotrexate—urinary bladder cancer	5.45e-05	0.000704	CcSEcCtD
Vincristine—Weight decreased—Doxorubicin—urinary bladder cancer	5.44e-05	0.000703	CcSEcCtD
Vincristine—Pneumonia—Doxorubicin—urinary bladder cancer	5.39e-05	0.000697	CcSEcCtD
Vincristine—Gastrointestinal pain—Etoposide—urinary bladder cancer	5.39e-05	0.000696	CcSEcCtD
Vincristine—Hypersensitivity—Cisplatin—urinary bladder cancer	5.3e-05	0.000685	CcSEcCtD
Vincristine—Diarrhoea—Gemcitabine—urinary bladder cancer	5.28e-05	0.000682	CcSEcCtD
Vincristine—Neuropathy peripheral—Doxorubicin—urinary bladder cancer	5.26e-05	0.000679	CcSEcCtD
Vincristine—Stomatitis—Doxorubicin—urinary bladder cancer	5.23e-05	0.000675	CcSEcCtD
Vincristine—Abdominal pain—Etoposide—urinary bladder cancer	5.21e-05	0.000673	CcSEcCtD
Vincristine—Body temperature increased—Etoposide—urinary bladder cancer	5.21e-05	0.000673	CcSEcCtD
Vincristine—Diarrhoea—Fluorouracil—urinary bladder cancer	5.2e-05	0.000671	CcSEcCtD
Vincristine—Hypoaesthesia—Epirubicin—urinary bladder cancer	5.18e-05	0.000669	CcSEcCtD
Vincristine—Asthenia—Cisplatin—urinary bladder cancer	5.17e-05	0.000667	CcSEcCtD
Vincristine—Cardiac disorder—Methotrexate—urinary bladder cancer	5.16e-05	0.000666	CcSEcCtD
Vincristine—Sweating—Doxorubicin—urinary bladder cancer	5.14e-05	0.000664	CcSEcCtD
Vincristine—Urinary tract disorder—Epirubicin—urinary bladder cancer	5.14e-05	0.000664	CcSEcCtD
Vincristine—Connective tissue disorder—Epirubicin—urinary bladder cancer	5.11e-05	0.00066	CcSEcCtD
Vincristine—Urethral disorder—Epirubicin—urinary bladder cancer	5.1e-05	0.000659	CcSEcCtD
Vincristine—ABCB1—lymph node—urinary bladder cancer	5.1e-05	0.00128	CbGeAlD
Vincristine—Angiopathy—Methotrexate—urinary bladder cancer	5.04e-05	0.000651	CcSEcCtD
Vincristine—Dizziness—Fluorouracil—urinary bladder cancer	5.02e-05	0.000648	CcSEcCtD
Vincristine—Mediastinal disorder—Methotrexate—urinary bladder cancer	5.01e-05	0.000647	CcSEcCtD
Vincristine—Diarrhoea—Cisplatin—urinary bladder cancer	4.93e-05	0.000636	CcSEcCtD
Vincristine—Alopecia—Methotrexate—urinary bladder cancer	4.91e-05	0.000634	CcSEcCtD
Vincristine—Vomiting—Gemcitabine—urinary bladder cancer	4.91e-05	0.000634	CcSEcCtD
Vincristine—Mental disorder—Methotrexate—urinary bladder cancer	4.87e-05	0.000629	CcSEcCtD
Vincristine—Rash—Gemcitabine—urinary bladder cancer	4.87e-05	0.000629	CcSEcCtD
Vincristine—Dermatitis—Gemcitabine—urinary bladder cancer	4.87e-05	0.000628	CcSEcCtD
Vincristine—Hypersensitivity—Etoposide—urinary bladder cancer	4.86e-05	0.000627	CcSEcCtD
Vincristine—Headache—Gemcitabine—urinary bladder cancer	4.84e-05	0.000625	CcSEcCtD
Vincristine—Cardiac disorder—Epirubicin—urinary bladder cancer	4.83e-05	0.000624	CcSEcCtD
Vincristine—Vomiting—Fluorouracil—urinary bladder cancer	4.83e-05	0.000623	CcSEcCtD
Vincristine—Hypoaesthesia—Doxorubicin—urinary bladder cancer	4.79e-05	0.000619	CcSEcCtD
Vincristine—Rash—Fluorouracil—urinary bladder cancer	4.79e-05	0.000618	CcSEcCtD
Vincristine—Dermatitis—Fluorouracil—urinary bladder cancer	4.78e-05	0.000618	CcSEcCtD
Vincristine—Headache—Fluorouracil—urinary bladder cancer	4.76e-05	0.000614	CcSEcCtD
Vincristine—Urinary tract disorder—Doxorubicin—urinary bladder cancer	4.75e-05	0.000614	CcSEcCtD
Vincristine—Asthenia—Etoposide—urinary bladder cancer	4.73e-05	0.000611	CcSEcCtD
Vincristine—Connective tissue disorder—Doxorubicin—urinary bladder cancer	4.73e-05	0.000611	CcSEcCtD
Vincristine—Angiopathy—Epirubicin—urinary bladder cancer	4.72e-05	0.00061	CcSEcCtD
Vincristine—Urethral disorder—Doxorubicin—urinary bladder cancer	4.72e-05	0.000609	CcSEcCtD
Vincristine—Mediastinal disorder—Epirubicin—urinary bladder cancer	4.69e-05	0.000606	CcSEcCtD
Vincristine—Back pain—Methotrexate—urinary bladder cancer	4.68e-05	0.000605	CcSEcCtD
Vincristine—Alopecia—Epirubicin—urinary bladder cancer	4.6e-05	0.000594	CcSEcCtD
Vincristine—Nausea—Gemcitabine—urinary bladder cancer	4.59e-05	0.000592	CcSEcCtD
Vincristine—Vomiting—Cisplatin—urinary bladder cancer	4.58e-05	0.000591	CcSEcCtD
Vincristine—Mental disorder—Epirubicin—urinary bladder cancer	4.56e-05	0.000589	CcSEcCtD
Vincristine—Rash—Cisplatin—urinary bladder cancer	4.54e-05	0.000586	CcSEcCtD
Vincristine—Dermatitis—Cisplatin—urinary bladder cancer	4.53e-05	0.000586	CcSEcCtD
Vincristine—Diarrhoea—Etoposide—urinary bladder cancer	4.51e-05	0.000583	CcSEcCtD
Vincristine—Nausea—Fluorouracil—urinary bladder cancer	4.51e-05	0.000582	CcSEcCtD
Vincristine—Anaemia—Methotrexate—urinary bladder cancer	4.47e-05	0.000578	CcSEcCtD
Vincristine—Cardiac disorder—Doxorubicin—urinary bladder cancer	4.47e-05	0.000577	CcSEcCtD
Vincristine—Back pain—Epirubicin—urinary bladder cancer	4.38e-05	0.000566	CcSEcCtD
Vincristine—Angiopathy—Doxorubicin—urinary bladder cancer	4.37e-05	0.000564	CcSEcCtD
Vincristine—Dizziness—Etoposide—urinary bladder cancer	4.36e-05	0.000563	CcSEcCtD
Vincristine—Vertigo—Methotrexate—urinary bladder cancer	4.35e-05	0.000562	CcSEcCtD
Vincristine—Mediastinal disorder—Doxorubicin—urinary bladder cancer	4.34e-05	0.00056	CcSEcCtD
Vincristine—Leukopenia—Methotrexate—urinary bladder cancer	4.33e-05	0.000559	CcSEcCtD
Vincristine—Nausea—Cisplatin—urinary bladder cancer	4.28e-05	0.000552	CcSEcCtD
Vincristine—Alopecia—Doxorubicin—urinary bladder cancer	4.25e-05	0.000549	CcSEcCtD
Vincristine—Mental disorder—Doxorubicin—urinary bladder cancer	4.22e-05	0.000545	CcSEcCtD
Vincristine—Convulsion—Methotrexate—urinary bladder cancer	4.19e-05	0.000542	CcSEcCtD
Vincristine—Vomiting—Etoposide—urinary bladder cancer	4.19e-05	0.000541	CcSEcCtD
Vincristine—Anaemia—Epirubicin—urinary bladder cancer	4.19e-05	0.000541	CcSEcCtD
Vincristine—Agitation—Epirubicin—urinary bladder cancer	4.16e-05	0.000537	CcSEcCtD
Vincristine—Rash—Etoposide—urinary bladder cancer	4.16e-05	0.000537	CcSEcCtD
Vincristine—Dermatitis—Etoposide—urinary bladder cancer	4.15e-05	0.000536	CcSEcCtD
Vincristine—Headache—Etoposide—urinary bladder cancer	4.13e-05	0.000533	CcSEcCtD
Vincristine—Myalgia—Methotrexate—urinary bladder cancer	4.12e-05	0.000532	CcSEcCtD
Vincristine—Vertigo—Epirubicin—urinary bladder cancer	4.07e-05	0.000525	CcSEcCtD
Vincristine—Leukopenia—Epirubicin—urinary bladder cancer	4.05e-05	0.000524	CcSEcCtD
Vincristine—Back pain—Doxorubicin—urinary bladder cancer	4.05e-05	0.000523	CcSEcCtD
Vincristine—Anaphylactic shock—Methotrexate—urinary bladder cancer	3.95e-05	0.00051	CcSEcCtD
Vincristine—Convulsion—Epirubicin—urinary bladder cancer	3.92e-05	0.000507	CcSEcCtD
Vincristine—Infection—Methotrexate—urinary bladder cancer	3.92e-05	0.000507	CcSEcCtD
Vincristine—Nausea—Etoposide—urinary bladder cancer	3.92e-05	0.000506	CcSEcCtD
Vincristine—Hypertension—Epirubicin—urinary bladder cancer	3.91e-05	0.000505	CcSEcCtD
Vincristine—Nervous system disorder—Methotrexate—urinary bladder cancer	3.87e-05	0.0005	CcSEcCtD
Vincristine—Anaemia—Doxorubicin—urinary bladder cancer	3.87e-05	0.0005	CcSEcCtD
Vincristine—Thrombocytopenia—Methotrexate—urinary bladder cancer	3.87e-05	0.000499	CcSEcCtD
Vincristine—Myalgia—Epirubicin—urinary bladder cancer	3.86e-05	0.000498	CcSEcCtD
Vincristine—Agitation—Doxorubicin—urinary bladder cancer	3.85e-05	0.000497	CcSEcCtD
Vincristine—Hyperhidrosis—Methotrexate—urinary bladder cancer	3.82e-05	0.000493	CcSEcCtD
Vincristine—Vertigo—Doxorubicin—urinary bladder cancer	3.77e-05	0.000486	CcSEcCtD
Vincristine—Anorexia—Methotrexate—urinary bladder cancer	3.77e-05	0.000486	CcSEcCtD
Vincristine—Leukopenia—Doxorubicin—urinary bladder cancer	3.75e-05	0.000484	CcSEcCtD
Vincristine—Anaphylactic shock—Epirubicin—urinary bladder cancer	3.7e-05	0.000477	CcSEcCtD
Vincristine—Oedema—Epirubicin—urinary bladder cancer	3.7e-05	0.000477	CcSEcCtD
Vincristine—Hypotension—Methotrexate—urinary bladder cancer	3.69e-05	0.000477	CcSEcCtD
Vincristine—Infection—Epirubicin—urinary bladder cancer	3.67e-05	0.000474	CcSEcCtD
Vincristine—Convulsion—Doxorubicin—urinary bladder cancer	3.63e-05	0.000469	CcSEcCtD
Vincristine—Nervous system disorder—Epirubicin—urinary bladder cancer	3.63e-05	0.000468	CcSEcCtD
Vincristine—Thrombocytopenia—Epirubicin—urinary bladder cancer	3.62e-05	0.000467	CcSEcCtD
Vincristine—Hypertension—Doxorubicin—urinary bladder cancer	3.62e-05	0.000467	CcSEcCtD
Vincristine—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	3.6e-05	0.000465	CcSEcCtD
Vincristine—Hyperhidrosis—Epirubicin—urinary bladder cancer	3.57e-05	0.000461	CcSEcCtD
Vincristine—Insomnia—Methotrexate—urinary bladder cancer	3.57e-05	0.000461	CcSEcCtD
Vincristine—Myalgia—Doxorubicin—urinary bladder cancer	3.57e-05	0.000461	CcSEcCtD
Vincristine—Paraesthesia—Methotrexate—urinary bladder cancer	3.55e-05	0.000458	CcSEcCtD
Vincristine—Anorexia—Epirubicin—urinary bladder cancer	3.52e-05	0.000455	CcSEcCtD
Vincristine—Hypotension—Epirubicin—urinary bladder cancer	3.45e-05	0.000446	CcSEcCtD
Vincristine—Decreased appetite—Methotrexate—urinary bladder cancer	3.43e-05	0.000443	CcSEcCtD
Vincristine—Oedema—Doxorubicin—urinary bladder cancer	3.42e-05	0.000442	CcSEcCtD
Vincristine—Anaphylactic shock—Doxorubicin—urinary bladder cancer	3.42e-05	0.000442	CcSEcCtD
Vincristine—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	3.41e-05	0.00044	CcSEcCtD
Vincristine—Fatigue—Methotrexate—urinary bladder cancer	3.41e-05	0.00044	CcSEcCtD
Vincristine—Infection—Doxorubicin—urinary bladder cancer	3.4e-05	0.000439	CcSEcCtD
Vincristine—Pain—Methotrexate—urinary bladder cancer	3.38e-05	0.000436	CcSEcCtD
Vincristine—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	3.37e-05	0.000435	CcSEcCtD
Vincristine—Nervous system disorder—Doxorubicin—urinary bladder cancer	3.35e-05	0.000433	CcSEcCtD
Vincristine—Thrombocytopenia—Doxorubicin—urinary bladder cancer	3.35e-05	0.000432	CcSEcCtD
Vincristine—Insomnia—Epirubicin—urinary bladder cancer	3.34e-05	0.000432	CcSEcCtD
Vincristine—Paraesthesia—Epirubicin—urinary bladder cancer	3.32e-05	0.000429	CcSEcCtD
Vincristine—Hyperhidrosis—Doxorubicin—urinary bladder cancer	3.31e-05	0.000427	CcSEcCtD
Vincristine—Anorexia—Doxorubicin—urinary bladder cancer	3.26e-05	0.000421	CcSEcCtD
Vincristine—Gastrointestinal pain—Methotrexate—urinary bladder cancer	3.23e-05	0.000417	CcSEcCtD
Vincristine—Decreased appetite—Epirubicin—urinary bladder cancer	3.21e-05	0.000415	CcSEcCtD
Vincristine—Hypotension—Doxorubicin—urinary bladder cancer	3.2e-05	0.000413	CcSEcCtD
Vincristine—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	3.19e-05	0.000412	CcSEcCtD
Vincristine—Fatigue—Epirubicin—urinary bladder cancer	3.19e-05	0.000412	CcSEcCtD
Vincristine—Constipation—Epirubicin—urinary bladder cancer	3.16e-05	0.000408	CcSEcCtD
Vincristine—Pain—Epirubicin—urinary bladder cancer	3.16e-05	0.000408	CcSEcCtD
Vincristine—Abdominal pain—Methotrexate—urinary bladder cancer	3.12e-05	0.000403	CcSEcCtD
Vincristine—Body temperature increased—Methotrexate—urinary bladder cancer	3.12e-05	0.000403	CcSEcCtD
Vincristine—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	3.12e-05	0.000402	CcSEcCtD
Vincristine—Insomnia—Doxorubicin—urinary bladder cancer	3.09e-05	0.000399	CcSEcCtD
Vincristine—Paraesthesia—Doxorubicin—urinary bladder cancer	3.07e-05	0.000397	CcSEcCtD
Vincristine—Gastrointestinal pain—Epirubicin—urinary bladder cancer	3.02e-05	0.00039	CcSEcCtD
Vincristine—Decreased appetite—Doxorubicin—urinary bladder cancer	2.97e-05	0.000384	CcSEcCtD
Vincristine—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	2.95e-05	0.000381	CcSEcCtD
Vincristine—Fatigue—Doxorubicin—urinary bladder cancer	2.95e-05	0.000381	CcSEcCtD
Vincristine—Pain—Doxorubicin—urinary bladder cancer	2.93e-05	0.000378	CcSEcCtD
Vincristine—Constipation—Doxorubicin—urinary bladder cancer	2.93e-05	0.000378	CcSEcCtD
Vincristine—Body temperature increased—Epirubicin—urinary bladder cancer	2.92e-05	0.000377	CcSEcCtD
Vincristine—Abdominal pain—Epirubicin—urinary bladder cancer	2.92e-05	0.000377	CcSEcCtD
Vincristine—Hypersensitivity—Methotrexate—urinary bladder cancer	2.91e-05	0.000376	CcSEcCtD
Vincristine—Asthenia—Methotrexate—urinary bladder cancer	2.83e-05	0.000366	CcSEcCtD
Vincristine—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	2.8e-05	0.000361	CcSEcCtD
Vincristine—Hypersensitivity—Epirubicin—urinary bladder cancer	2.72e-05	0.000352	CcSEcCtD
Vincristine—Abdominal pain—Doxorubicin—urinary bladder cancer	2.7e-05	0.000349	CcSEcCtD
Vincristine—Body temperature increased—Doxorubicin—urinary bladder cancer	2.7e-05	0.000349	CcSEcCtD
Vincristine—Diarrhoea—Methotrexate—urinary bladder cancer	2.7e-05	0.000349	CcSEcCtD
Vincristine—Asthenia—Epirubicin—urinary bladder cancer	2.65e-05	0.000342	CcSEcCtD
Vincristine—Dizziness—Methotrexate—urinary bladder cancer	2.61e-05	0.000337	CcSEcCtD
Vincristine—Diarrhoea—Epirubicin—urinary bladder cancer	2.53e-05	0.000327	CcSEcCtD
Vincristine—Hypersensitivity—Doxorubicin—urinary bladder cancer	2.52e-05	0.000325	CcSEcCtD
Vincristine—Vomiting—Methotrexate—urinary bladder cancer	2.51e-05	0.000324	CcSEcCtD
Vincristine—Rash—Methotrexate—urinary bladder cancer	2.49e-05	0.000322	CcSEcCtD
Vincristine—Dermatitis—Methotrexate—urinary bladder cancer	2.49e-05	0.000321	CcSEcCtD
Vincristine—Headache—Methotrexate—urinary bladder cancer	2.47e-05	0.00032	CcSEcCtD
Vincristine—Asthenia—Doxorubicin—urinary bladder cancer	2.45e-05	0.000317	CcSEcCtD
Vincristine—Dizziness—Epirubicin—urinary bladder cancer	2.44e-05	0.000316	CcSEcCtD
Vincristine—Vomiting—Epirubicin—urinary bladder cancer	2.35e-05	0.000304	CcSEcCtD
Vincristine—Nausea—Methotrexate—urinary bladder cancer	2.35e-05	0.000303	CcSEcCtD
Vincristine—Diarrhoea—Doxorubicin—urinary bladder cancer	2.34e-05	0.000302	CcSEcCtD
Vincristine—Rash—Epirubicin—urinary bladder cancer	2.33e-05	0.000301	CcSEcCtD
Vincristine—Dermatitis—Epirubicin—urinary bladder cancer	2.33e-05	0.000301	CcSEcCtD
Vincristine—Headache—Epirubicin—urinary bladder cancer	2.32e-05	0.000299	CcSEcCtD
Vincristine—Dizziness—Doxorubicin—urinary bladder cancer	2.26e-05	0.000292	CcSEcCtD
Vincristine—Nausea—Epirubicin—urinary bladder cancer	2.2e-05	0.000284	CcSEcCtD
Vincristine—Vomiting—Doxorubicin—urinary bladder cancer	2.17e-05	0.000281	CcSEcCtD
Vincristine—Rash—Doxorubicin—urinary bladder cancer	2.16e-05	0.000278	CcSEcCtD
Vincristine—Dermatitis—Doxorubicin—urinary bladder cancer	2.15e-05	0.000278	CcSEcCtD
Vincristine—Headache—Doxorubicin—urinary bladder cancer	2.14e-05	0.000277	CcSEcCtD
Vincristine—Nausea—Doxorubicin—urinary bladder cancer	2.03e-05	0.000262	CcSEcCtD
Vincristine—TUBB4B—Cell Cycle, Mitotic—EP300—urinary bladder cancer	9.92e-06	0.000247	CbGpPWpGaD
Vincristine—TUBA4A—Cell Cycle—TP53—urinary bladder cancer	9.85e-06	0.000245	CbGpPWpGaD
Vincristine—ABCC3—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	9.74e-06	0.000242	CbGpPWpGaD
Vincristine—TUBB4A—Cell Cycle—EP300—urinary bladder cancer	9.7e-06	0.000241	CbGpPWpGaD
Vincristine—CYP3A4—Biological oxidations—GSTP1—urinary bladder cancer	9.68e-06	0.000241	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle—CCND1—urinary bladder cancer	9.64e-06	0.00024	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—GSTZ1—urinary bladder cancer	9.63e-06	0.000239	CbGpPWpGaD
Vincristine—CYP3A4—Metapathway biotransformation—GSTP1—urinary bladder cancer	9.55e-06	0.000237	CbGpPWpGaD
Vincristine—ABCC1—Disease—RBX1—urinary bladder cancer	9.51e-06	0.000237	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—RHOA—urinary bladder cancer	9.48e-06	0.000236	CbGpPWpGaD
Vincristine—TUBB4A—Cell Cycle, Mitotic—MYC—urinary bladder cancer	9.45e-06	0.000235	CbGpPWpGaD
Vincristine—TUBB4A—Metabolism of proteins—CXCL8—urinary bladder cancer	9.43e-06	0.000234	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—SLC19A1—urinary bladder cancer	9.41e-06	0.000234	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—NQO1—urinary bladder cancer	9.41e-06	0.000234	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle—CDKN1A—urinary bladder cancer	9.32e-06	0.000232	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—NAT2—urinary bladder cancer	9.25e-06	0.00023	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—NAT2—urinary bladder cancer	9.17e-06	0.000228	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—PRSS3—urinary bladder cancer	9.17e-06	0.000228	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—urinary bladder cancer	9.14e-06	0.000227	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—GSTO2—urinary bladder cancer	9.13e-06	0.000227	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—NAT1—urinary bladder cancer	9.13e-06	0.000227	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—RRM2—urinary bladder cancer	9.07e-06	0.000226	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—urinary bladder cancer	9.03e-06	0.000225	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—NQO1—urinary bladder cancer	9.02e-06	0.000224	CbGpPWpGaD
Vincristine—NR0B1—Gene Expression—MYC—urinary bladder cancer	8.99e-06	0.000224	CbGpPWpGaD
Vincristine—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	8.9e-06	0.000221	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle—EP300—urinary bladder cancer	8.87e-06	0.000221	CbGpPWpGaD
Vincristine—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	8.78e-06	0.000218	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—ERBB2—urinary bladder cancer	8.77e-06	0.000218	CbGpPWpGaD
Vincristine—ABCB11—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	8.75e-06	0.000218	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—NQO1—urinary bladder cancer	8.65e-06	0.000215	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle, Mitotic—MYC—urinary bladder cancer	8.65e-06	0.000215	CbGpPWpGaD
Vincristine—TUBB4B—Metabolism of proteins—CXCL8—urinary bladder cancer	8.62e-06	0.000214	CbGpPWpGaD
Vincristine—ABCC1—Disease—JAG1—urinary bladder cancer	8.51e-06	0.000212	CbGpPWpGaD
Vincristine—TUBB4A—Cell Cycle—MYC—urinary bladder cancer	8.45e-06	0.00021	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—HPGDS—urinary bladder cancer	8.4e-06	0.000209	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—ENO2—urinary bladder cancer	8.4e-06	0.000209	CbGpPWpGaD
Vincristine—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	8.39e-06	0.000209	CbGpPWpGaD
Vincristine—TUBB—Cell Cycle—TP53—urinary bladder cancer	8.38e-06	0.000208	CbGpPWpGaD
Vincristine—ABCC1—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	8.36e-06	0.000208	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—UGT2B7—urinary bladder cancer	8.35e-06	0.000208	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—CXCL8—urinary bladder cancer	8.32e-06	0.000207	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—GSTT1—urinary bladder cancer	8.15e-06	0.000203	CbGpPWpGaD
Vincristine—ABCC1—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	8.03e-06	0.0002	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—RRM2—urinary bladder cancer	7.99e-06	0.000199	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—IL2—urinary bladder cancer	7.95e-06	0.000198	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—RRM2—urinary bladder cancer	7.91e-06	0.000197	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—GSTP1—urinary bladder cancer	7.84e-06	0.000195	CbGpPWpGaD
Vincristine—ABCB1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	7.76e-06	0.000193	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—CCND1—urinary bladder cancer	7.75e-06	0.000193	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle—MYC—urinary bladder cancer	7.73e-06	0.000192	CbGpPWpGaD
Vincristine—ABCC2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	7.72e-06	0.000192	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	7.66e-06	0.00019	CbGpPWpGaD
Vincristine—ABCC1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	7.63e-06	0.00019	CbGpPWpGaD
Vincristine—ABCB11—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	7.63e-06	0.00019	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—MMP9—urinary bladder cancer	7.53e-06	0.000187	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—GSTP1—urinary bladder cancer	7.52e-06	0.000187	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—CYP4B1—urinary bladder cancer	7.52e-06	0.000187	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—CDKN1A—urinary bladder cancer	7.5e-06	0.000186	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—urinary bladder cancer	7.49e-06	0.000186	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—PTEN—urinary bladder cancer	7.48e-06	0.000186	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—HPGDS—urinary bladder cancer	7.4e-06	0.000184	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—ENO2—urinary bladder cancer	7.4e-06	0.000184	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—HPGDS—urinary bladder cancer	7.33e-06	0.000182	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—ENO2—urinary bladder cancer	7.33e-06	0.000182	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—TYMP—urinary bladder cancer	7.33e-06	0.000182	CbGpPWpGaD
Vincristine—ABCC3—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	7.32e-06	0.000182	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—TYMS—urinary bladder cancer	7.29e-06	0.000181	CbGpPWpGaD
Vincristine—ABCB11—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	7.28e-06	0.000181	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—GSTP1—urinary bladder cancer	7.21e-06	0.000179	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—NCOR1—urinary bladder cancer	7.21e-06	0.000179	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—GSTM1—urinary bladder cancer	7.21e-06	0.000179	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—GSTT1—urinary bladder cancer	7.17e-06	0.000178	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—EP300—urinary bladder cancer	7.13e-06	0.000177	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—GSTT1—urinary bladder cancer	7.11e-06	0.000177	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—SLC19A1—urinary bladder cancer	7.1e-06	0.000176	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—TYMS—urinary bladder cancer	6.99e-06	0.000174	CbGpPWpGaD
Vincristine—ABCC3—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	6.98e-06	0.000173	CbGpPWpGaD
Vincristine—TUBB4A—Cell Cycle—TP53—urinary bladder cancer	6.94e-06	0.000173	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—SRC—urinary bladder cancer	6.94e-06	0.000172	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—PRSS3—urinary bladder cancer	6.92e-06	0.000172	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—GSTM1—urinary bladder cancer	6.91e-06	0.000172	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—NCOR1—urinary bladder cancer	6.91e-06	0.000172	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—GPX1—urinary bladder cancer	6.9e-06	0.000172	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—ERCC2—urinary bladder cancer	6.78e-06	0.000169	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—NQO1—urinary bladder cancer	6.77e-06	0.000168	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	6.77e-06	0.000168	CbGpPWpGaD
Vincristine—ABCG2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	6.72e-06	0.000167	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—TYMS—urinary bladder cancer	6.7e-06	0.000167	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—NAT2—urinary bladder cancer	6.63e-06	0.000165	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—GSTM1—urinary bladder cancer	6.63e-06	0.000165	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—NCOR1—urinary bladder cancer	6.63e-06	0.000165	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—GPX1—urinary bladder cancer	6.62e-06	0.000165	CbGpPWpGaD
Vincristine—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	6.57e-06	0.000163	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	6.55e-06	0.000163	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	6.53e-06	0.000162	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—ERCC2—urinary bladder cancer	6.5e-06	0.000162	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—MTHFR—urinary bladder cancer	6.37e-06	0.000158	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle—TP53—urinary bladder cancer	6.35e-06	0.000158	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—GPX1—urinary bladder cancer	6.35e-06	0.000158	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—ERCC2—urinary bladder cancer	6.23e-06	0.000155	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	6.23e-06	0.000155	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—MYC—urinary bladder cancer	6.22e-06	0.000155	CbGpPWpGaD
Vincristine—ABCC1—Disease—NCOR1—urinary bladder cancer	6.2e-06	0.000154	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—MTHFR—urinary bladder cancer	6.11e-06	0.000152	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—EGFR—urinary bladder cancer	6.08e-06	0.000151	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	6.06e-06	0.000151	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—NQO1—urinary bladder cancer	5.96e-06	0.000148	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	5.93e-06	0.000147	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—NQO1—urinary bladder cancer	5.91e-06	0.000147	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—MTHFR—urinary bladder cancer	5.86e-06	0.000146	CbGpPWpGaD
Vincristine—ABCC1—Disease—ERCC2—urinary bladder cancer	5.83e-06	0.000145	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—KRAS—urinary bladder cancer	5.74e-06	0.000143	CbGpPWpGaD
Vincristine—ABCC1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	5.73e-06	0.000143	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—RRM2—urinary bladder cancer	5.72e-06	0.000142	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—GSTP1—urinary bladder cancer	5.65e-06	0.00014	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	5.62e-06	0.00014	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—NAT1—urinary bladder cancer	5.62e-06	0.00014	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—TYMP—urinary bladder cancer	5.53e-06	0.000137	CbGpPWpGaD
Vincristine—ABCC1—Disease—MTHFR—urinary bladder cancer	5.48e-06	0.000136	CbGpPWpGaD
Vincristine—ABCC1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	5.47e-06	0.000136	CbGpPWpGaD
Vincristine—ABCC1—Disease—TERT—urinary bladder cancer	5.46e-06	0.000136	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	5.43e-06	0.000135	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	5.31e-06	0.000132	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—HPGDS—urinary bladder cancer	5.3e-06	0.000132	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—ENO2—urinary bladder cancer	5.3e-06	0.000132	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—TYMS—urinary bladder cancer	5.25e-06	0.000131	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—NCOR1—urinary bladder cancer	5.19e-06	0.000129	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—GSTM1—urinary bladder cancer	5.19e-06	0.000129	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—PPARG—urinary bladder cancer	5.17e-06	0.000128	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	5.14e-06	0.000128	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—GSTT1—urinary bladder cancer	5.14e-06	0.000128	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—TP53—urinary bladder cancer	5.11e-06	0.000127	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	5.06e-06	0.000126	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	5.01e-06	0.000125	CbGpPWpGaD
Vincristine—ABCC1—Disease—FGFR3—urinary bladder cancer	5.01e-06	0.000125	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—NAT2—urinary bladder cancer	5e-06	0.000124	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—GPX1—urinary bladder cancer	4.97e-06	0.000124	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—GSTP1—urinary bladder cancer	4.97e-06	0.000124	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—CREBBP—urinary bladder cancer	4.96e-06	0.000123	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—PPARG—urinary bladder cancer	4.95e-06	0.000123	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—GSTP1—urinary bladder cancer	4.93e-06	0.000123	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—HRAS—urinary bladder cancer	4.88e-06	0.000121	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—ERCC2—urinary bladder cancer	4.88e-06	0.000121	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—CREBBP—urinary bladder cancer	4.76e-06	0.000118	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—PPARG—urinary bladder cancer	4.75e-06	0.000118	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	4.63e-06	0.000115	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—TYMS—urinary bladder cancer	4.62e-06	0.000115	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—MTHFR—urinary bladder cancer	4.59e-06	0.000114	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—TYMS—urinary bladder cancer	4.58e-06	0.000114	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—NCOR1—urinary bladder cancer	4.57e-06	0.000114	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—GSTM1—urinary bladder cancer	4.57e-06	0.000114	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—CREBBP—urinary bladder cancer	4.56e-06	0.000113	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—NCOR1—urinary bladder cancer	4.53e-06	0.000113	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—GSTM1—urinary bladder cancer	4.53e-06	0.000113	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	4.46e-06	0.000111	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—GPX1—urinary bladder cancer	4.38e-06	0.000109	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	4.37e-06	0.000109	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—GPX1—urinary bladder cancer	4.34e-06	0.000108	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—RRM2—urinary bladder cancer	4.32e-06	0.000107	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—ERCC2—urinary bladder cancer	4.3e-06	0.000107	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—NQO1—urinary bladder cancer	4.27e-06	0.000106	CbGpPWpGaD
Vincristine—ABCC1—Disease—CREBBP—urinary bladder cancer	4.27e-06	0.000106	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	4.26e-06	0.000106	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—ERCC2—urinary bladder cancer	4.26e-06	0.000106	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—PTGS2—urinary bladder cancer	4.06e-06	0.000101	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—MTHFR—urinary bladder cancer	4.04e-06	0.0001	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—MTHFR—urinary bladder cancer	4e-06	9.95e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—HPGDS—urinary bladder cancer	4e-06	9.94e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—ENO2—urinary bladder cancer	4e-06	9.94e-05	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—PTGS2—urinary bladder cancer	3.9e-06	9.69e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—GSTT1—urinary bladder cancer	3.88e-06	9.64e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—RHOA—urinary bladder cancer	3.86e-06	9.6e-05	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—PTGS2—urinary bladder cancer	3.74e-06	9.29e-05	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—PPARG—urinary bladder cancer	3.72e-06	9.25e-05	CbGpPWpGaD
Vincristine—ABCB1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	3.63e-06	9.03e-05	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—CREBBP—urinary bladder cancer	3.57e-06	8.89e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—ERBB2—urinary bladder cancer	3.57e-06	8.89e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—GSTP1—urinary bladder cancer	3.56e-06	8.86e-05	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—PTEN—urinary bladder cancer	3.54e-06	8.81e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—PTGS2—urinary bladder cancer	3.5e-06	8.69e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—TYMP—urinary bladder cancer	3.41e-06	8.47e-05	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—PTEN—urinary bladder cancer	3.4e-06	8.45e-05	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—EP300—urinary bladder cancer	3.38e-06	8.4e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—TYMS—urinary bladder cancer	3.31e-06	8.23e-05	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—PPARG—urinary bladder cancer	3.27e-06	8.14e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—GSTM1—urinary bladder cancer	3.27e-06	8.14e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—NCOR1—urinary bladder cancer	3.27e-06	8.14e-05	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—PTEN—urinary bladder cancer	3.26e-06	8.1e-05	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—PPARG—urinary bladder cancer	3.25e-06	8.07e-05	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—EP300—urinary bladder cancer	3.24e-06	8.06e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—NQO1—urinary bladder cancer	3.22e-06	8.01e-05	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—CREBBP—urinary bladder cancer	3.15e-06	7.82e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—GPX1—urinary bladder cancer	3.13e-06	7.79e-05	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—CREBBP—urinary bladder cancer	3.12e-06	7.75e-05	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—EP300—urinary bladder cancer	3.11e-06	7.72e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—NAT2—urinary bladder cancer	3.08e-06	7.66e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—ERCC2—urinary bladder cancer	3.08e-06	7.65e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—CDKN1A—urinary bladder cancer	3.06e-06	7.6e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—PTEN—urinary bladder cancer	3.05e-06	7.58e-05	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—PTGS2—urinary bladder cancer	2.93e-06	7.28e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—EP300—urinary bladder cancer	2.91e-06	7.23e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—MTHFR—urinary bladder cancer	2.89e-06	7.19e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—SRC—urinary bladder cancer	2.83e-06	7.03e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—GSTP1—urinary bladder cancer	2.69e-06	6.68e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—RRM2—urinary bladder cancer	2.66e-06	6.61e-05	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—PTGS2—urinary bladder cancer	2.58e-06	6.4e-05	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—PTGS2—urinary bladder cancer	2.55e-06	6.35e-05	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—PTEN—urinary bladder cancer	2.55e-06	6.35e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—MYC—urinary bladder cancer	2.53e-06	6.3e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—TYMS—urinary bladder cancer	2.5e-06	6.21e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—EGFR—urinary bladder cancer	2.48e-06	6.16e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—NCOR1—urinary bladder cancer	2.47e-06	6.14e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—GSTM1—urinary bladder cancer	2.47e-06	6.14e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	2.46e-06	6.12e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—ENO2—urinary bladder cancer	2.46e-06	6.12e-05	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—EP300—urinary bladder cancer	2.43e-06	6.05e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	2.39e-06	5.94e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—GPX1—urinary bladder cancer	2.37e-06	5.88e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—PPARG—urinary bladder cancer	2.35e-06	5.83e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—KRAS—urinary bladder cancer	2.34e-06	5.82e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—ERCC2—urinary bladder cancer	2.32e-06	5.77e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—CREBBP—urinary bladder cancer	2.25e-06	5.6e-05	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—PTEN—urinary bladder cancer	2.25e-06	5.58e-05	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—PTEN—urinary bladder cancer	2.23e-06	5.54e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—MTHFR—urinary bladder cancer	2.18e-06	5.43e-05	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—EP300—urinary bladder cancer	2.14e-06	5.33e-05	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—EP300—urinary bladder cancer	2.12e-06	5.28e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—HRAS—urinary bladder cancer	1.99e-06	4.95e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—NQO1—urinary bladder cancer	1.99e-06	4.94e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—PTGS2—urinary bladder cancer	1.85e-06	4.59e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—PPARG—urinary bladder cancer	1.77e-06	4.4e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—CREBBP—urinary bladder cancer	1.7e-06	4.23e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	1.66e-06	4.12e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—PTEN—urinary bladder cancer	1.61e-06	4e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—TYMS—urinary bladder cancer	1.54e-06	3.83e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—EP300—urinary bladder cancer	1.53e-06	3.82e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	1.52e-06	3.78e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	1.52e-06	3.78e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—GPX1—urinary bladder cancer	1.46e-06	3.62e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	1.43e-06	3.56e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—PTGS2—urinary bladder cancer	1.39e-06	3.46e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	1.34e-06	3.34e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—PTEN—urinary bladder cancer	1.21e-06	3.02e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—EP300—urinary bladder cancer	1.16e-06	2.88e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—PPARG—urinary bladder cancer	1.09e-06	2.71e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	1.05e-06	2.6e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	8.58e-07	2.13e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—PTEN—urinary bladder cancer	7.48e-07	1.86e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—EP300—urinary bladder cancer	7.14e-07	1.77e-05	CbGpPWpGaD
